Total assets increased 50.9%
Total assets changed +50.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$150.1M→$226.4M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →OOMA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables increased 31.9%
Trade receivables changed +31.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$8.6M→$11.4M4 prior comparisons
Capital expenditure increased 74.6%
Capital expenditure changed +74.6% from the comparable as-filed period.
$1.3M→$2.3M3 prior comparisons
Gross profit increased 26.7%
Gross profit changed +26.7% from the comparable as-filed period.
$40.2M→$51.0M2 prior comparisons
Cash & equivalents decreased 10.4%
Cash & equivalents changed -10.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$19.6M→$17.5M4 prior comparisons
Research & development increased 23.8%
Research & development changed +23.8% from the comparable as-filed period.
$12.5M→$15.5M2 prior comparisons
Current assets increased 16.0%
Current assets changed +16.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$59.8M→$69.3M4 prior comparisons
Working capital changed across a sign change
Working capital changed -135.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
$9.4M→-$3.3M4 prior comparisons
Shares outstanding unchangedd 0.0%
Shares outstanding changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
27,600,000→27,600,0008 prior comparisons
Stock-based compensation increased 0.8%
Stock-based compensation changed +0.8% from the comparable as-filed period.
$3.6M→$3.7M2 prior comparisons
Gross profit increased 26.0%
Gross profit changed +26.0% from the comparable as-filed period.
$40.2M→$50.7M3 prior comparisons
Inventory increased 27.3%
Inventory changed +27.3% from the comparable as-filed period.
$14.1M→$18.0M3 prior comparisons
Operating income changed across a sign change
Operating income changed +6254.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$57,000→$3.5M3 prior comparisons
Research & development increased 20.8%
Research & development changed +20.8% from the comparable as-filed period.
$12.4M→$15.0M3 prior comparisons
Cash & equivalents decreased 9.6%
Cash & equivalents changed -9.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$19.0M→$17.2M2 prior comparisons
Net income changed across a sign change
Net income changed +1931.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$141,000→$2.6M2 prior comparisons
Stock-based compensation decreased 11.1%
Stock-based compensation changed -11.1% from the comparable as-filed period.
$3.9M→$3.5M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.